Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma
Ben George(Medical College of Wisconsin), Susan Tsai(The Ohio State University Wexner Medical Center), Andrey Kravets(Addgene), Mandana Kamgar(Medical College of Wisconsin), Lolita Alekseeva(Addgene), A. Bagaev(Addgene), Bradley A. Erickson(Medical College of Wisconsin), Samih Z Thalji(Medical College of Wisconsin), Razelle Kurzrock(Medical College of Wisconsin), Isha Sethi(Boston Children's Hospital), Kathleen K. Christians(Medical College of Wisconsin), Bradley Taylor(Medical College of Wisconsin), Thomas McFall(Salk Institute for Biological Studies), Dmitry Tychinin(Addgene), Subramaniam Malarkannan(Versiti Blood Center of Wisconsin), Douglas B. Evans(The University of Texas MD Anderson Cancer Center), Anna Butusova(Addgene), E. F. Chernyavskaya(Medical College of Wisconsin), Egor V. Savin(Addgene), Dandan Wang(Peking University), Nara Shin(Addgene), Jessica H. Brown(Addgene), Olga Kudryashova(Addgene), William A. Hall(Medical College of Wisconsin), Mariia Gusakova(Addgene), Dmitry Kravchenko(Addgene)
Cited by 33
Related Papers
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
|Molecular Cancer Therapeutics|2015|2.3k
Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology
|Radiotherapy and Oncology|2006|1.6k
Epstein-Barr Virus and Cancer
|Clinical Cancer Research|2004|795
Review of precision cancer medicine: Evolution of the treatment paradigm
|Cancer Treatment Reviews|2020|747